Amgen buys $66 million stake in genetics device company
Thousand Oaks biotech giant Amgen broadened its reach into genetics research Oct. 18 with a $66 million investment in handheld DNA sequencing company Oxford Nanopore Technologies. Genetics has been a research focus for Amgen since its 2012 acquisition of deCODE, particularly in the area of Alzheimer’s therapies. The news follows closely the release by Oxford Read More →
Read More →Interior Secretary Zinke renews wind energy bids near Morro Bay
Offshore wind projects on the Central Coast caught an updraft Oct. 18 when U.S. Secretary of the Interior Ryan Zinke released a call for information and nominations to identify companies interested in commercial projects. The backing by the Trump administration moves forward a proposal concept that had been stalled by an assessment by the U.S. Navy Read More →
Read More →Teledyne Technologies buys West Virginia firm
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Amgen launches Humira biosimilar in Europe
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →MannKind stock soars after it closes $105 million deal
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →